Results 111 to 120 of about 25,547 (271)
Novel KPC‐25 and first‐reported KPC‐127 sequentially evolved in one patient under CAZ‐AVI pressure, distinct mutations remodel enzyme activity to drive differential multidrug resistance. ABSTRACT The emergence of novel Klebsiella pneumoniae carbapenemase (KPC) variants contributing to clinical treatment failure poses a substantial threat to public ...
Ke Lei +8 more
wiley +1 more source
Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects [PDF]
Balaji Veeraraghavan +3 more
doaj +1 more source
Universal‐Bac3Gel, a 3D biofilm‐relevant matrix with oxygen and nutrient gradients, supports the growth and species‐specific biofilm architectures of all ESKAPE pathogens, offering a physiologically relevant platform for antimicrobial testing and microbiological research. ABSTRACT Human microbiota is increasingly considered to shape health and disease,
Emanuela Peluso +5 more
wiley +1 more source
Introduction: The escalating prevalence of multidrug resistance is a global threat to human health particularly in critically ill patients with bloodstream infections (BSIs).
Seema Gangar +4 more
doaj
HB&L System: rapid determination of antibiotic sensitivity of bacteria isolated from blood cultures.
Introduction. Blood culture is an important method to detect microbial pathogens on blood, very useful for diagnosing bacterial infections. Unfortunately, classical diagnostic protocols cannot directly identify bacteria responsible for sepsis and ...
Simone Barocci +6 more
doaj +1 more source
Using 16,040 stool samples from healthy individuals across 30 Chinese provinces (2016–2024), we performed longitudinal genomic surveillance of carbapenem‑resistant Klebsiella pneumoniae (CRKP) colonizing the gut. We reveal rising community CRKP prevalence, especially in southern China, a shift from blaKPC‐2 to plasmid‑borne blaNDM‐5 on IncHI2/IncHI2A ...
Zelin Yan +11 more
wiley +1 more source
Antimicrobial Stewardship Strategies for Implementing the 2019 EUCAST ‘I’ Definition
Abstract Background In 2019, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) redefined the “I” category from “intermediate susceptibility” to “susceptible, provided increased exposure”.
Evelyne Van den Broucke +6 more
openaire +3 more sources
Prediction of Antimicrobial Resistance in People Living With Cystic Fibrosis Using Machine Learning
Using routinely collected electronic healthcare record data from patients with cystic fibrosis, machine learning models predicted antimicrobial resistance in sputum cultures before susceptibility results were available. Extreme gradient boosting showed consistent discrimination across five commonly tested antibiotics, with AUCs of 0.75–0.80.
Junrong Jiang +10 more
wiley +1 more source
EUCAST Technical Note on tigecycline [PDF]
Brown, D.F.J. +11 more
openaire +2 more sources

